Phase II Study of 21 Day Schedule Oral Etoposide in Children

By the New Agents Group of the United Kingdom Children's Cancer Study Group UKCCSG   Davidson A.   Gowing R.   Lowis S.   Newell D.   Lewis I.   Dicks-Mireaux C.   Pinkerton C.R.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1816-1822

Elsevier

Access to resources Recommend Favorite

Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: Association with severe myelotoxicity

By Bar-Sela Gil   Gaitini Diana   Steiner Mariana   Haim Nissim  

Medical Oncology, Vol. 20, Iss. 3, 2003-09 ,pp. : 291-294

Humana Press, Inc

Access to resources Recommend Favorite

Oral etoposide in patients with hematological malignancies: A clinical and pharmacokinetic study

By Ösby E.   Liliemark E.   Björkholm M.   Liliemark J.  

Medical Oncology, Vol. 18, Iss. 4, 2001-12 ,pp. : 269-275

Humana Press, Inc

Access to resources Recommend Favorite

A Phase II Study of Prolonged Oral Etoposide in Advanced or Recurrent Carcinoma of the Cervix

By Morris M.   Brader K.R.   Burke T.W.   Levenback C.F.   Gershenson D.M.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 215-218

Elsevier

Access to resources Recommend Favorite

EORTC Group phase II study of oral etoposide for pretreated soft

By Keizer H. Jan   Crowther Derek   Nielsen Ole Steen   Oosterom Allan T. Van   Muguiro Javier Hornedo   Pottelberghe Christine Van   Somers Renier   Tursz Thomas  

Sarcoma, Vol. 1, Iss. 2, 1997-06 ,pp. : 99-102

Informa Healthcare

Access to resources Recommend Favorite